TELO GENOMICS CORPTELO GENOMICS CORPTELO GENOMICS CORP

TELO GENOMICS CORP

No trades
See on Supercharts

TELO fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. Its products include Telomere Science and Teloview. The company was founded by Sabine Mai on May 25, 2011 and is headquartered in Toronto, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

TELO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company